About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD0.86
- USD1.05
- USD0.86
- USD4.20
- -17.60%
- 2M
- 98.96k
- 33.40k
- 23M
- 0.79
- -77.90%
Stock News
1 hour ago
Sonos Announces Date for Second Quarter Fiscal 2024 Financial Results and Conference Call
Yahoo
1 hour ago
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Yahoo
2 hours ago
Equitrans Midstream Schedules First Quarter 2024 Earnings Release Date
Yahoo
2 hours ago
GoPro Announces First Quarter 2024 Earnings Webcast
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
